A YouGov survey this month shows half of the respondents (49%) do not plan to take the vaccine or are not sure. . . . → Read More: Infographic – Half of US Public Still Not Taking Vaccine
|
|||||
A YouGov survey this month shows half of the respondents (49%) do not plan to take the vaccine or are not sure. . . . → Read More: Infographic – Half of US Public Still Not Taking Vaccine An analysis of health records suggests people vaccinated earlier against childhood and adult infectious diseases are also less likely to contract Covid-19. . . . → Read More: Other Vaccinations Shown to Help Prevent Covid-19 A clinical trial shows homes installed with devices that attract then kill mosquitos have fewer malaria cases than homes with standard preventions. . . . → Read More: Trial Shows Home Mosquito Device Cuts Malaria Cases A maker of diagnostics that examine exhaled breath and an artificial intelligence chip provider are developing a simple breath test for Covid-19 infections. . . . → Read More: Tech Companies Partner on Covid-19 Breath Test A provider of drug discovery services based on artificial intelligence says in 18 months it identified and tested in mice a new drug for a chronic lung disease. . . . → Read More: AI Process Discovers, Tests Fibrosis Drug in 18 Months A start-up company, spun off from a biomedical engineering lab at MIT, is raising $80 million for therapies made from synthetic circular RNA. . . . → Read More: Synthetic RNA Start-Up Gains $80M in Early Funds A developer of therapies using highly precise gene editing is acquiring a company delivering gene therapies identified with DNA bar codes. . . . → Read More: Gene-Editing Biotech Acquires DNA Bar Code Company There are things to understand about Malaysia’s property market, mainly relating to taxes and selling your properties. . . . → Read More: What Happens When Property is Sold in Malaysia? An ALS treatment developer says the Food and Drug Administration advised the company’s clinical trial data would likely not support approval for patient use. . . . → Read More: ALS Trial Results Deemed Insufficient for FDA Approval Food and Drug Administration is updating its regulatory guidance for Covid-19 drugs and diagnostics to cover emerging mutations in the SARS-CoV-2 virus. . . . → Read More: FDA Issues Covid-19 Variant Regulatory Guidance |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |